Streetbeat News

Partnerships

HSAI

Hesai has been chosen as the LiDAR supplier for Li Auto's new model, Li MEGA, marking a significant partnership in the automotive and technology sectors.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:48 pm

OMQS

OMNIQ Corp. has received a purchase order from Burger Ranch for the supply of self-ordering kiosks, self-check-out kiosks, and a new feature supporting cash transactions. This development signifies an expansion of OMNIQ's market presence in the fast-food industry and highlights the growing trend of automation in retail and hospitality sectors.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:46 pm

DTIL

Precision BioSciences has announced that its partner, iECURE, received MHRA approval to expand the Phase 1/2 clinical trial of the ARCUS gene editing program for treating OTC deficiency. This development marks a significant step forward in the application of gene editing technologies in addressing genetic disorders.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:45 pm

HBIO

Harvard Bioscience, Inc. (NASDAQ:HBIO) announced its participation in the Society of Toxicology conference in Salt Lake City from March 11-13, 2024, showcasing its latest product innovations for preclinical and organoid applications. The company introduced the Ponemah Data Management Platform, SoHo Implantable Telemetry, VivaMARS Activity Monitoring System, and Mesh MEA Organoid Platform, highlighting their integration and potential for advancing therapy development with AI and machine learning technologies.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:40 pm

PINC

Premier, Inc. has announced a clinical research collaboration with McLaren Health Care through its PINC AI Applied Sciences division. The partnership aims to advance patient outcomes by leveraging Premier's healthcare performance improvement capabilities and McLaren's healthcare delivery expertise.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:39 pm

INKT

MiNK Therapeutics, Inc. (NASDAQ:INKT) announced preclinical data for MiNK-215, a novel CAR-iNKT cell therapy for colorectal cancer liver metastases, showcasing its potential in enhancing tumor killing and T-cell response. The data will be presented at AACR 2024. MiNK-215 targets FAP-expressing cells, increasing CD8+ T cell infiltration. The therapy is being developed in partnership with Agenus, leveraging their ICIs, botensilimab/balstilimab, to potentially improve outcomes for patients with treatment-refractory MSS colorectal cancer liver metastases.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:37 pm

SPY

UNG

Saudi Aramco and UAE's ADNOC are reportedly in discussions to invest in US LNG projects, signaling a significant interest in the expanding US liquefied natural gas sector. This move could enhance the global LNG supply chain and strengthen ties between these oil-rich nations and the US energy market.

Portfolio Pulse from Charles Gross

March 06, 2024 | 1:21 pm

FCOM

META

NVDA

XLC

Meta Platforms Inc (NASDAQ:META) is ending its authorized sales partner program to directly engage with advertisers, aiming for operational standardization. Entravision Communications, a key partner, is reassessing its strategy due to the program's significant revenue contribution. Meta's AI investments, including Nvidia Corp's (NASDAQ:NVDA) H100 GPUs, have been well-received, contrasting its earlier metaverse strategy. Investors can access Meta through ETFs like The Communication Services Select Sector SPDR Fund (NYSE:XLC) and Fidelity MSCI Communication Services Index ETF (NYSE:FCOM).

Portfolio Pulse from Anusuya Lahiri

March 06, 2024 | 1:20 pm

CTSH

MSFT

Cognizant and Microsoft have announced a collaboration to integrate generative AI into healthcare administration through the TriZetto platform, which is powered by Azure OpenAI Service. This initiative aims to reduce hidden costs and improve patient outcomes for millions of Americans.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:14 pm

AISP

CRWD

EVC

MRAI

CrowdStrike Holdings, Inc. (CRWD) shares surged 24.4% in pre-market trading after reporting better-than-expected Q4 earnings and revenues, and issuing upbeat FY25 guidance. Other stocks also moved significantly in pre-market trading, with notable gainers including NKGen Biotech, Inc. (NKGN), Marpai, Inc. (MRAI), and Airship AI Holdings, Inc. (AISP). Losers included Entravision Communications Corporation (EVC) and Heart Test Laboratories, Inc. (HSCS).

Portfolio Pulse from Avi Kapoor

March 06, 2024 | 1:14 pm